Galmed Pharmaceuticals
GLMD
#10237
Rank
C$5.09 M
Marketcap
$2.26
Share price
10.88%
Change (1 day)
-61.85%
Change (1 year)

Earnings for Galmed Pharmaceuticals (GLMD)

Earnings in 2024 (TTM): -C$8.52 Million

According to Galmed Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$9.57 Million, an increase over its 2022 earnings that were of -C$24.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galmed Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$8.52 Million-10.98%
2023 -C$9.57 Million-61.31%
2022 -C$24.74 Million-44.97%
2021 -C$44.95 Million12.85%
2020 -C$39.84 Million40.61%
2019 -C$28.33 Million109.19%
2018 -C$13.55 Million-20.47%
2017 -C$17.03 Million-27%
2016 -C$23.33 Million58.6%
2015 -C$14.71 Million16.7%
2014 -C$12.61 Million-47.94%
2013 -C$24.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.13 Billion 1,338.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$3.32 Billion 37,722.90%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-C$32.18 Million 267.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$6.72 Million-23.30%๐Ÿ‡บ๐Ÿ‡ธ USA